Latest filing published 01 Nov 2022 for Relay Therapeutics, Inc., €9,681. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Andy Porter is a declared insider of Relay Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 8 filings, for trades running from 27 December 2021 to 28 October 2022.
Sales make up the whole of the open-market record (7 sales, €56k). The rest of the record consists of 1 share grant. 2022 to date brings no purchases and 6 sales.
Most recently, on 1 November 2022, the filings show an open-market sale worth €9,681 in Relay Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations